This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2024 Zacks Investment Research | 10 S Riverside Plaza Suite #1600 | Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.68% per year. These returns cover a period from January 1, 1988 through August 5, 2024. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
Zacks News
Medtronic's (MDT) Q1 Earnings Beat Estimates, Margins Fall
by Zacks Equity Research
Barring Respiratory, Gastrointestinal & Renal, Medtronic (MDT) registers dismal performance in all business segments and geographies in Q1.
PDCO vs. CNMD: Which Stock Should Value Investors Buy Now?
by Zacks Equity Research
PDCO vs. CNMD: Which Stock Is the Better Value Option?
5 PEG-Driven Value Stocks to Invest in Coronavirus-Hit Market
by Urmimala Biswas
PEG ratio is complicated, considering the limitations in calculating the future earnings growth potential of a stock.
Is Patterson Cos. (PDCO) Stock Undervalued Right Now?
by Zacks Equity Research
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
Has Patterson Companies (PDCO) Outpaced Other Medical Stocks This Year?
by Zacks Equity Research
Is (PDCO) Outperforming Other Medical Stocks This Year?
PDCO vs. COO: Which Stock Should Value Investors Buy Now?
by Zacks Equity Research
PDCO vs. COO: Which Stock Is the Better Value Option?
Patterson Cos. (PDCO) Hits 52-Week High, Can the Run Continue?
by Zacks Equity Research
Patterson Cos. (PDCO) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.
Will Patterson Cos. (PDCO) Beat Estimates Again in Its Next Earnings Report?
by Zacks Equity Research
Patterson Cos. (PDCO) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
Boston Scientific (BSX) Q2 Earnings Top, Margins Decline
by Zacks Equity Research
This time too Boston Scientific (BSX) refrains from providing any update on the full-year guidance.
Amedisys (AMED) Earnings and Revenues Beat Estimates in Q2
by Zacks Equity Research
Amedisys' (AMED) second-quarter results reflect impressive performance by the Hospice division despite pandemic-led challenges.
Omnicell (OMCL) Q2 Earnings Lag Estimates, Margins Down
by Zacks Equity Research
Omnicell's (OMCL) second-quarter revenues suffered due to slowdown in hospital purchasing decisions and product bookings owing to pandemic-led business disruptions.
Top Ranked Income Stocks to Buy for July 28th
by Zacks Equity Research
Here are four stocks with buy rank and strong income characteristics for investors to consider today, July 28th.
Top Ranked Growth Stocks to Buy for July 28th
by Zacks Equity Research
Here are three stocks with buy ranks and strong growth characteristics for investors to consider today, July 28th
Are Investors Undervaluing Patterson Cos. (PDCO) Right Now?
by Zacks Equity Research
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
Patterson Cos. (PDCO) Up 17.2% Since Last Earnings Report: Can It Continue?
by Zacks Equity Research
Patterson Cos. (PDCO) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
PDCO vs. CNMD: Which Stock Is the Better Value Option?
by Zacks Equity Research
PDCO vs. CNMD: Which Stock Is the Better Value Option?
Calix, Weibo, Lowe's, Sportsman's Warehouse and Patterson Companies highlighted as Zacks Bull and Bear of the Day
by Zacks Equity Research
Calix, Weibo, Lowe's, Sportsman's Warehouse and Patterson Companies highlighted as Zacks Bull and Bear of the Day
Patterson Cos. (PDCO) Hits Fresh High: Is There Still Room to Run?
by Zacks Equity Research
Patterson Cos. (PDCO) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.
Top Ranked Income Stocks to Buy for July 20th
by Zacks Equity Research
Here are three stocks with buy rank and strong income characteristics for investors to consider today, July 20th.
3 Large-Cap MedTech Stocks to Buy on Northbound Market Trend
by Sriparna Ghosal
Backed by an upward trend of share prices and projections of robust earnings growth rates, there are a few MedTech stocks which are ideal for long-term bet.
3 Value Stocks Near 52-Week Highs
by James Giaquinto
3 Value Stocks Near 52-Week Highs
Merit Medical (MMSI) Looks Good: Stock Adds 6.7% in Session
by Zacks Equity Research
Merit Medical (MMSI) saw a big move last session, as its shares jumped more than 6% on the day, amid huge volumes.
Top Ranked Growth Stocks to Buy for July 15th
by Zacks Equity Research
Here are four stocks with buy ranks and strong growth characteristics for investors to consider today, July 15th.
4 Best MedTech Stocks to Combat Coronavirus Crisis on Strong ROE
by Debanjana Dey
Here are some MedTech stocks which might be solid investment options for profit-maximization amid the coronavirus-led market mayhem.
Top Ranked Growth Stocks to Buy for July 14th
by Zacks Equity Research
Here are four stocks with buy ranks and strong growth characteristics for investors to consider today, July 14th.